Holst Stephanie, Deuss Anna J M, van Pelt Gabi W, van Vliet Sandra J, Garcia-Vallejo Juan J, Koeleman Carolien A M, Deelder André M, Mesker Wilma E, Tollenaar Rob A, Rombouts Yoann, Wuhrer Manfred
From the ‡Center for Proteomics and Metabolomics.
§Department of Surgery, and.
Mol Cell Proteomics. 2016 Jan;15(1):124-40. doi: 10.1074/mcp.M115.051235. Epub 2015 Nov 4.
Various cancers such as colorectal cancer (CRC) are associated with alterations in protein glycosylation. CRC cell lines are frequently used to study these (glyco)biological changes and their mechanisms. However, differences between CRC cell lines with regard to their glycosylation have hitherto been largely neglected. Here, we comprehensively characterized the N-glycan profiles of 25 different CRC cell lines, derived from primary tumors and metastatic sites, in order to investigate their potential as glycobiological tumor model systems and to reveal glycans associated with cell line phenotypes. We applied an optimized, high-throughput membrane-based enzymatic glycan release for small sample amounts. Released glycans were derivatized to stabilize and differentiate between α2,3- and α2,6-linked N-acetylneuraminic acids, followed by N-glycosylation analysis by MALDI-TOF(/TOF)-MS. Our results showed pronounced differences between the N-glycosylation patterns of CRC cell lines. CRC cell line profiles differed from tissue-derived N-glycan profiles with regard to their high-mannose N-glycan content but showed a large overlap for complex type N-glycans, supporting their use as a glycobiological cancer model system. Importantly, we could show that the high-mannose N-glycans did not only occur as intracellular precursors but were also present at the cell surface. The obtained CRC cell line N-glycan features were not clearly correlated with mRNA expression levels of glycosyltransferases, demonstrating the usefulness of performing the structural analysis of glycans. Finally, correlation of CRC cell line glycosylation features with cancer cell markers and phenotypes revealed an association between highly fucosylated glycans and CDX1 and/or villin mRNA expression that both correlate with cell differentiation. Together, our findings provide new insights into CRC-associated glycan changes and setting the basis for more in-depth experiments on glycan function and regulation.
多种癌症,如结直肠癌(CRC),都与蛋白质糖基化改变有关。CRC细胞系经常被用于研究这些(糖基化)生物学变化及其机制。然而,迄今为止,CRC细胞系之间在糖基化方面的差异在很大程度上被忽视了。在这里,我们全面表征了25种不同的CRC细胞系(源自原发性肿瘤和转移部位)的N-聚糖谱,以研究它们作为糖生物学肿瘤模型系统的潜力,并揭示与细胞系表型相关的聚糖。我们应用了一种优化的、基于膜的高通量酶促聚糖释放方法来处理少量样本。释放的聚糖经过衍生化处理,以稳定并区分α2,3-和α2,6-连接的N-乙酰神经氨酸,随后通过基质辅助激光解吸电离飞行时间(/串联飞行时间)质谱(MALDI-TOF(/TOF)-MS)进行N-糖基化分析。我们的结果显示CRC细胞系的N-糖基化模式存在显著差异。CRC细胞系谱在高甘露糖型N-聚糖含量方面与组织来源的N-聚糖谱不同,但在复合型N-聚糖方面有很大重叠,这支持了它们作为糖生物学癌症模型系统的用途。重要的是,我们能够证明高甘露糖型N-聚糖不仅作为细胞内前体存在,也存在于细胞表面。所获得的CRC细胞系N-聚糖特征与糖基转移酶的mRNA表达水平没有明显相关性,这表明进行聚糖结构分析是有用的。最后,CRC细胞系糖基化特征与癌细胞标志物和表型的相关性揭示了高岩藻糖基化聚糖与CDX1和/或绒毛蛋白mRNA表达之间的关联(两者均与细胞分化相关)。总之,我们的研究结果为CRC相关的聚糖变化提供了新的见解,并为更深入的聚糖功能和调控实验奠定了基础。